139 related articles for article (PubMed ID: 9148412)
61. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
Straube E; Nimmich W; Broschewitz U; Naumann G
Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
[TBL] [Abstract][Full Text] [Related]
62. Immunization of ewes with E. coli surface proteins to protect offspring against experimentally induced colibacillosis.
Awad-Masalmeh M; Willinger H
Zentralbl Veterinarmed B; 1985 Aug; 32(7):548-54. PubMed ID: 2865860
[No Abstract] [Full Text] [Related]
63. A new candidate vaccine for Escherichia coli pyelonephritis.
Stapleton A
J Urol; 2004 Apr; 171(4):1686-7. PubMed ID: 15017267
[No Abstract] [Full Text] [Related]
64. [Immunostimulating activity of certain subcellular fractions of Escherichia coli O138:K81:H19].
Ruskova M
Vet Med Nauki; 1979; 16(1):28-32. PubMed ID: 388840
[TBL] [Abstract][Full Text] [Related]
65. Modern vaccines. Enteric infections.
Levine MM
Lancet; 1990 Apr; 335(8695):958-61. PubMed ID: 1970034
[No Abstract] [Full Text] [Related]
66. F18
Won G; Lee JH
Comp Immunol Microbiol Infect Dis; 2018 Jun; 58():44-51. PubMed ID: 30245050
[TBL] [Abstract][Full Text] [Related]
67. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
68. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
[TBL] [Abstract][Full Text] [Related]
69. [Immunoprevention of colibacillary enteritis in infants with a mixed peroral coli vaccine].
Wiedermannová D; Wiedermann D; Korych B; Holcíková A
Cas Lek Cesk; 1983 Aug; 122(32-33):994-9. PubMed ID: 6354458
[No Abstract] [Full Text] [Related]
70. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
[TBL] [Abstract][Full Text] [Related]
71. Role of bacterial lectins in urinary tract infections. Molecular mechanisms for diversification of bacterial surface lectins.
Ofek I; Hasty DL; Abraham SN; Sharon N
Adv Exp Med Biol; 2000; 485():183-92. PubMed ID: 11109105
[No Abstract] [Full Text] [Related]
72. [Molecular analysis of uropathogenic strains of Escherichia coli and the clinical course of urinary tract infection in children].
Rytlewska M; Liberek A; Sikorska-Wisniewska G; Zalewska B; Kurlenda J; Korzon M
Med Wieku Rozwoj; 2005; 9(4):727-39. PubMed ID: 16733281
[TBL] [Abstract][Full Text] [Related]
73. Effects of subinhibitory concentrations of antibiotics and antibodies on the adherence of Escherichia coli to human uroepithelial cells in vitro.
Stenqvist K; Sandberg T; Ahlstedt S; Korhonen TK; Svanborg-Edén C
Scand J Infect Dis Suppl; 1982; 33():104-7. PubMed ID: 6127798
[No Abstract] [Full Text] [Related]
74. A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli.
Melamed D; Leitner G; Heller ED
Avian Dis; 1991; 35(1):17-22. PubMed ID: 2029251
[TBL] [Abstract][Full Text] [Related]
75. [Treatment of urinary tract infections with SolcoUrovac].
Litschgi M
Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132
[TBL] [Abstract][Full Text] [Related]
76. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
[TBL] [Abstract][Full Text] [Related]
77. Microbiology. Pods invade infected bladders.
Ferber D
Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
[No Abstract] [Full Text] [Related]
78. Synthetic peptides: prospects for a pili (fimbriae)-based synthetic vaccine.
Schmidt MA
Curr Top Microbiol Immunol; 1990; 151():185-204. PubMed ID: 1973370
[No Abstract] [Full Text] [Related]
79. Vaginal immunization against induced cystitis in monkeys.
Uehling DT; Hopkins WJ; Jensen J; Balish E
J Urol; 1987 Feb; 137(2):327-9. PubMed ID: 3543412
[TBL] [Abstract][Full Text] [Related]
80. Adhesins as targets for vaccine development.
Wizemann TM; Adamou JE; Langermann S
Emerg Infect Dis; 1999; 5(3):395-403. PubMed ID: 10341176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
